[go: up one dir, main page]

FI922316L - Farmaceutisk sammansaettning - Google Patents

Farmaceutisk sammansaettning Download PDF

Info

Publication number
FI922316L
FI922316L FI922316A FI922316A FI922316L FI 922316 L FI922316 L FI 922316L FI 922316 A FI922316 A FI 922316A FI 922316 A FI922316 A FI 922316A FI 922316 L FI922316 L FI 922316L
Authority
FI
Finland
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
FI922316A
Other languages
English (en)
Other versions
FI922316A0 (fi
FI109333B (fi
Inventor
Friedrich Richter
Marianne Roser
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919111210A external-priority patent/GB9111210D0/en
Priority claimed from GB929204472A external-priority patent/GB9204472D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI922316A0 publication Critical patent/FI922316A0/fi
Publication of FI922316L publication Critical patent/FI922316L/fi
Application granted granted Critical
Publication of FI109333B publication Critical patent/FI109333B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI922316A 1991-05-23 1992-05-21 Menetelmä topikaalisen valmisteen valmistamiseksi FI109333B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB919111210A GB9111210D0 (en) 1991-05-23 1991-05-23 Pharmaceutical composition
GB9111210 1991-05-23
GB929204472A GB9204472D0 (en) 1992-03-02 1992-03-02 Pharmaceutical composition
GB9204472 1992-03-02

Publications (3)

Publication Number Publication Date
FI922316A0 FI922316A0 (fi) 1992-05-21
FI922316L true FI922316L (fi) 1992-11-24
FI109333B FI109333B (fi) 2002-07-15

Family

ID=26298942

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922316A FI109333B (fi) 1991-05-23 1992-05-21 Menetelmä topikaalisen valmisteen valmistamiseksi

Country Status (30)

Country Link
US (3) US5866105A (fi)
EP (1) EP0515312B1 (fi)
JP (1) JP3527749B2 (fi)
KR (1) KR100367150B1 (fi)
AT (1) AT400518B (fi)
AU (1) AU642090B2 (fi)
CA (1) CA2069153C (fi)
CH (1) CH683237A5 (fi)
CY (1) CY2070B1 (fi)
CZ (1) CZ284232B6 (fi)
DE (1) DE4215677B4 (fi)
DK (1) DK0515312T3 (fi)
ES (1) ES2091441T3 (fi)
FI (1) FI109333B (fi)
FR (1) FR2676647B1 (fi)
GB (1) GB2256138B (fi)
GR (1) GR3021551T3 (fi)
HU (1) HU219480B (fi)
IE (1) IE66476B1 (fi)
IL (1) IL101944A (fi)
IT (1) IT1254571B (fi)
LU (1) LU88117A1 (fi)
MX (1) MX9202407A (fi)
NO (1) NO300084B1 (fi)
NZ (1) NZ242849A (fi)
PH (1) PH31205A (fi)
RO (1) RO112081B1 (fi)
RU (1) RU2110257C1 (fi)
SK (1) SK281130B6 (fi)
ZA (1) ZA923765B (fi)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
US5464610A (en) * 1992-10-15 1995-11-07 Schering-Plough Healthcare Products, Inc. Method for treating onychomycosis
DK128494A (da) * 1994-11-08 1996-05-09 Edel K Seidenschnur Behandling af keratinøse og psoriatiske sygdomstilstande med neglelak indeholdende vitamin D metabolit, eller derivat, og/eller vitamin A derivat
DE19643831A1 (de) 1996-10-30 1998-05-07 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung von schwer therapierbaren Schleimhauterkrankungen
BR9708081A (pt) * 1996-03-16 1999-07-27 Hoechst Ag Formulações tópicas para tratamento de psóriase de unhas
US20040039030A1 (en) 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
DE19639816A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
DE19639817A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung von Hautinfektionen
RO118174B1 (ro) 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia
US6605751B1 (en) * 1997-11-14 2003-08-12 Acrymed Silver-containing compositions, devices and methods for making
US6727401B1 (en) 1998-02-12 2004-04-27 Watson Pharmaceuticals, Inc. Pressure sensitive adhesive matrix patch for the treatment of onychomycosis
AU745321B2 (en) * 1998-04-17 2002-03-21 Bertek Pharmaceuticals, Inc. Topical formulations for the treatment of nail fungal diseases
AU3753700A (en) * 1999-03-16 2000-10-04 Mark Yezbick A fingernail coating composition
US6403063B1 (en) 1999-07-26 2002-06-11 Kenneth I. Sawyer Method of treating nail fungus
DE19949517A1 (de) * 1999-10-14 2001-04-19 Henkel Kgaa Festigende Haarreinigungsmittel
ATE327779T1 (de) 1999-12-30 2006-06-15 Acrymed Methode und zusammensetzungen für verbesserte abgabevorrichtungen
DE10011081A1 (de) * 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel
GB0014448D0 (en) * 2000-06-13 2000-08-09 Novartis Ag Organic compounds
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
GB0019283D0 (en) * 2000-08-04 2000-09-27 Novartis Ag Organic compounds
JP4803511B2 (ja) * 2000-08-25 2011-10-26 株式会社ポーラファルマ 抗真菌医薬組成物
GB0103046D0 (en) 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US6878365B2 (en) * 2001-03-10 2005-04-12 James Edward Brehove Topical application for treating toenail fungus
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
ATE352292T1 (de) * 2001-09-04 2007-02-15 Trommsdorff Arzneimittel Pflaster mit sertaconazol zur behandlung von nagelfunktionsstörungen und erkrankungen
RU2190394C1 (ru) * 2001-11-08 2002-10-10 ОАО Нижегородский химико-фармацевтический завод Фармацевтический состав, обладающий противогрибковой активностью, и способ его получения
RU2207124C1 (ru) * 2002-04-24 2003-06-27 Закрытое акционерное общество "Брынцалов-А" Крем "брамизил" противогрибкового действия
US6921529B2 (en) * 2002-07-29 2005-07-26 Joseph C. Maley Treatment modality and method for fungal nail infection
CN1678277B (zh) 2002-07-29 2010-05-05 艾克里麦德公司 治疗皮肤病的方法和组合物
US20030049307A1 (en) * 2002-08-15 2003-03-13 Gyurik Robert J. Pharmaceutical composition
US20060035983A1 (en) * 2002-08-20 2006-02-16 Pinnell Sheldon R Methods for treating fungal infections
US20040126343A1 (en) * 2002-12-26 2004-07-01 Garshowitz Solomon David Nail drug delivery
WO2004084826A2 (en) * 2003-03-21 2004-10-07 Nexmed Holdings, Inc. Antifungal nail coat and method of use
CN101829319A (zh) * 2003-12-08 2010-09-15 Cpex药品公司 用于胰岛素治疗的药用组合物及方法
CN102783499A (zh) * 2004-07-30 2012-11-21 金伯利-克拉克环球有限公司 抗微生物的装置和组合物
NZ592438A (en) * 2004-07-30 2012-11-30 Kimberly Clark Co Antimicrobial compositions of silver nanoparticles
US8361553B2 (en) 2004-07-30 2013-01-29 Kimberly-Clark Worldwide, Inc. Methods and compositions for metal nanoparticle treated surfaces
US9289378B2 (en) * 2004-09-20 2016-03-22 Avent, Inc. Antimicrobial amorphous compositions
FR2878157B1 (fr) * 2004-11-23 2007-03-02 Durlin France Sa Composition de vernis a base de solvant a base de solvant d'origine vegetale
US20060165747A1 (en) * 2005-01-24 2006-07-27 David Rolf Antifungal composition, method and kit for topically treating onychomycosis
AU2006298748B2 (en) * 2005-09-29 2010-06-03 Karo Healthcare AB Antifungal composition
CN101262848B (zh) * 2005-09-29 2011-05-11 诺瓦提斯公司 抗真菌组合物
WO2007076619A1 (en) * 2006-01-02 2007-07-12 Tlt Medical Ltd. Pharmaceutical composition for the treatment of nail diseases
RU2311186C1 (ru) * 2006-02-06 2007-11-27 Леснова Наталья Витальевна Биологически активный компонент, обладающий противогрибковым действием, и противогрибковый лечебно-косметический лак демиктен на его основе
WO2007127236A2 (en) * 2006-04-28 2007-11-08 Acrymed, Inc. Antimicrobial site dressings
EP2120870A2 (en) * 2007-02-21 2009-11-25 Power Paper Ltd. Terbinafine formulation for iontophoresis
US20090082469A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched terbinafine
GB0720716D0 (en) * 2007-10-23 2007-12-05 York Pharma Plc Novel formulation
WO2010069519A1 (en) * 2008-12-18 2010-06-24 Merz Pharma Gmbh & Co. Kgaa Topical compositions comprising at least one active ingredient poorly soluble in water and biopolymers such as hyaluronic acid with a pka-value between 5-7
ES2468540T3 (es) * 2009-02-13 2014-06-16 Topica Pharmaceuticals, Inc Formulación antif�ngica
FR2942716B1 (fr) * 2009-03-06 2011-04-15 Galderma Res & Dev Methode de solubilisation d'agent antifongique et compositions a haute concentration en agent antifongique applicables sur l'ongle
JP5992324B2 (ja) * 2009-03-20 2016-09-14 スティーフェル ラボラトリーズ インコーポレイテッド 脂肪酸モノグリセリド組成物
KR20150027831A (ko) 2012-07-06 2015-03-12 레오 파마 에이/에스 피부에 활성 성분을 전달하기 위한 막-형성 중합체를 포함하는 국소 조성물
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2002795B (en) * 1977-07-15 1982-03-17 Mallinckrodt Inc Nail enamel compositions their preparation and use
US5132459A (en) * 1979-08-22 1992-07-21 Sandoz Ltd. Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
ATE10272T1 (de) * 1979-08-22 1984-11-15 Sandoz Ag Propenylamine, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und ihre verwendung als arzneimittel.
JPH01501143A (ja) * 1985-11-04 1989-04-20 ダ−マトロジカル・プロダクツ・オブ・テキサス 爪への薬物の施用のための皮膜形成性製剤用ヴェヒクル、これらのヴェヒクルを基にした薬剤組成物および同じものの使用法
DE3544983A1 (de) * 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
US4782059A (en) * 1986-09-29 1988-11-01 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
HU200914B (en) * 1987-03-09 1990-09-28 Horvath Gyoengyi Lengyelne Process for producing new medical dosage unit suitable for local treatment of fungus infection of nails
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
LU86924A1 (fr) * 1987-06-19 1989-03-08 Oreal Vernis a ongles anhydres
US4920109A (en) * 1988-04-18 1990-04-24 Merck & Co., Inc. Antifungal compositions and method of controlling mycotic infections
US5160737A (en) * 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
US5116603A (en) * 1989-01-31 1992-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oral antifungal preventative, and method of use
CA2008775C (en) * 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
FR2646603B1 (fr) * 1989-05-03 1991-07-12 Oreal Composition nettoyante
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
FR2666962B1 (fr) * 1990-09-26 1996-06-14 Oreal Composition antifongique sous forme de spray sec.
FR2673537B1 (fr) 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására

Also Published As

Publication number Publication date
IL101944A0 (en) 1992-12-30
CS153292A3 (en) 1992-12-16
HK1000242A1 (en) 1998-02-13
ATA105892A (de) 1995-06-15
RO112081B1 (ro) 1997-05-30
GB2256138B (en) 1995-01-11
SK281130B6 (sk) 2000-12-11
CZ284232B6 (cs) 1998-09-16
IE921670A1 (en) 1992-12-02
NO300084B1 (no) 1997-04-07
CA2069153A1 (en) 1992-11-24
IT1254571B (it) 1995-09-25
EP0515312B1 (en) 1996-08-14
EP0515312A2 (en) 1992-11-25
FR2676647B1 (fr) 1995-05-12
AU1705892A (en) 1992-11-26
KR920021140A (ko) 1992-12-18
CA2069153C (en) 2002-12-17
KR100367150B1 (ko) 2003-03-03
FI922316A0 (fi) 1992-05-21
FI109333B (fi) 2002-07-15
FR2676647A1 (fr) 1992-11-27
NO922006L (no) 1992-11-24
ZA923765B (en) 1993-11-22
LU88117A1 (fr) 1993-12-06
CY2070B1 (en) 1998-09-11
HUT62467A (en) 1993-05-28
PH31205A (en) 1998-05-05
NZ242849A (en) 1993-09-27
JPH05148136A (ja) 1993-06-15
US6214360B1 (en) 2001-04-10
DK0515312T3 (da) 1996-11-18
JP3527749B2 (ja) 2004-05-17
ITRM920381A1 (it) 1993-11-22
US6319509B1 (en) 2001-11-20
GR3021551T3 (en) 1997-02-28
MX9202407A (es) 1992-11-01
AT400518B (de) 1996-01-25
AU642090B2 (en) 1993-10-07
GB2256138A (en) 1992-12-02
EP0515312A3 (en) 1993-04-14
GB9210974D0 (en) 1992-07-08
US5866105A (en) 1999-02-02
IL101944A (en) 1998-07-15
RU2110257C1 (ru) 1998-05-10
DE4215677A1 (de) 1992-11-26
IE66476B1 (en) 1995-12-27
ITRM920381A0 (it) 1992-05-22
NO922006D0 (no) 1992-05-21
HU9201548D0 (en) 1992-07-28
CH683237A5 (de) 1994-02-15
DE4215677B4 (de) 2008-01-17
ES2091441T3 (es) 1996-11-01
HU219480B (hu) 2001-04-28

Similar Documents

Publication Publication Date Title
EE03108B1 (et) Farmatseutiline kompositsioon
FI981777A7 (fi) Farmaseuttinen ainekoostumus
FI922316L (fi) Farmaceutisk sammansaettning
FI925661L (fi) Injicerbar farmaceutisk komposition
NO923127L (no) Farmasoeytisk kombinasjonsformulering
DK0585252T3 (da) Farmaceutiske formuleringer
FI923582L (fi) Farmaceutisk sferoidkomposition
FI944832A0 (fi) Farmaseuttinen koostumus
DE4291156T1 (de) Verbesserte pharmazeutische Zusammensetzungen
BR9200058A (pt) Composto e composicao farmaceutica
FI933467A7 (fi) Koostumus
MX9200622A (es) Composicion farmaceutica
ITMI932540A0 (it) Composizione farmaceutica
DE4294862T1 (de) Pharmazeutische Komposition
UA26064A1 (uk) Фармацевтичhа композиція
LV10579A (lv) Farmaceitiska kompozicija
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
FI921785A7 (fi) Farmaceutisk foerening
FI921786A7 (fi) Farmaceutisk foerening
FI920911A7 (fi) Bis-bibensimidazolkomposition
BR9202742A (pt) Composicao delimpeza
FI925175A0 (fi) Kompositioner haerdbara medelst straolning
SE9101348D0 (sv) Pharmaceutical composition
SE9103213D0 (sv) Farmaceutisk komposition
ITMI912766A1 (it) Composizione farmaceutica contenente n-acetil-cisteina

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

MA Patent expired